These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

953 related items for PubMed ID: 20158954

  • 1. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment.
    Fayed N, Dávila J, Oliveros A, Medrano J, Castillo J.
    Neurol Res; 2010 Mar; 32(2):157-65. PubMed ID: 20158954
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J, Zimny A, Knysz B, Małyszczak K, Kołtowska A, Szewczyk P, Gąsiorowski J, Furdal M, Sąsiadek MJ.
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [Abstract] [Full Text] [Related]

  • 3. Multimodal imaging in diagnosis of Alzheimer's disease and amnestic mild cognitive impairment: value of magnetic resonance spectroscopy, perfusion, and diffusion tensor imaging of the posterior cingulate region.
    Zimny A, Szewczyk P, Trypka E, Wojtynska R, Noga L, Leszek J, Sasiadek M.
    J Alzheimers Dis; 2011 Oct; 27(3):591-601. PubMed ID: 21841260
    [Abstract] [Full Text] [Related]

  • 4. Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia.
    Fayed N, Dávila J, Oliveros A, Castillo J, Medrano JJ.
    Acad Radiol; 2008 Sep; 15(9):1089-98. PubMed ID: 18692749
    [Abstract] [Full Text] [Related]

  • 5. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM, Gavrila D, Antúnez C, Tormo MJ, Salmerón D, Carles R, Jiménez Veiga J, Parrilla G, Torres del Río S, Fortuna L, Navarro C.
    Dement Geriatr Cogn Disord; 2008 Sep; 26(1):15-25. PubMed ID: 18566544
    [Abstract] [Full Text] [Related]

  • 6. [Cognitive impairment: classification by proton magnetic resonance spectroscopy and the contributions of conventional magnetic resonance imaging].
    Martínez-Bisbal MC, Arana E, Martí-Bonmatí L, Martínez-Granados B, Celda B.
    Radiologia; 2006 Sep; 48(5):301-7. PubMed ID: 17168239
    [Abstract] [Full Text] [Related]

  • 7. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z, Zhao C, Yu L, Zhou W, Li K.
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [Abstract] [Full Text] [Related]

  • 8. Diffusion tensor imaging correlates with proton magnetic resonance spectroscopy in posterior cingulate region of patients with Alzheimer's disease.
    Ding B, Chen KM, Ling HW, Zhang H, Chai WM, Li X, Wang T.
    Dement Geriatr Cogn Disord; 2008 Apr; 25(3):218-25. PubMed ID: 18219201
    [Abstract] [Full Text] [Related]

  • 9. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy.
    Modrego PJ, Fayed N, Pina MA.
    Am J Psychiatry; 2005 Apr; 162(4):667-75. PubMed ID: 15800137
    [Abstract] [Full Text] [Related]

  • 10. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.
    Waldman AD, Rai GS.
    Neuroradiology; 2003 Aug; 45(8):507-12. PubMed ID: 12879326
    [Abstract] [Full Text] [Related]

  • 11. Differences in brain metabolism associated with agitation and depression in Alzheimer's disease.
    Tsai CF, Hung CW, Lirng JF, Wang SJ, Fuh JL.
    East Asian Arch Psychiatry; 2013 Sep; 23(3):86-90. PubMed ID: 24088401
    [Abstract] [Full Text] [Related]

  • 12. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [Abstract] [Full Text] [Related]

  • 13. Congenital muscular dystrophy with merosin deficiency: 1H MR spectroscopy and diffusion-weighted MR imaging.
    Leite CC, Reed UC, Otaduy MC, Lacerda MT, Costa MO, Ferreira LG, Carvalho MS, Resende MB, Marie SK, Cerri GG.
    Radiology; 2005 Apr; 235(1):190-6. PubMed ID: 15703311
    [Abstract] [Full Text] [Related]

  • 14. 1H-proton magnetic resonance spectroscopy differentiates dementia with Lewy bodies from Alzheimer's disease.
    Zhong X, Shi H, Shen Z, Hou L, Luo X, Chen X, Liu S, Zhang Y, Zheng D, Tan Y, Huang G, Fang Y, Zhang H, Mu N, Chen J, Wu R, Ning Y.
    J Alzheimers Dis; 2014 Apr; 40(4):953-66. PubMed ID: 24531156
    [Abstract] [Full Text] [Related]

  • 15. In vivo evaluation of brain damage in the course of systemic lupus erythematosus using magnetic resonance spectroscopy, perfusion-weighted and diffusion-tensor imaging.
    Zimny A, Szmyrka-Kaczmarek M, Szewczyk P, Bladowska J, Pokryszko-Dragan A, Gruszka E, Wiland P, Sasiadek M.
    Lupus; 2014 Apr; 23(1):10-9. PubMed ID: 24192079
    [Abstract] [Full Text] [Related]

  • 16. Metabolite investigation in both anterior and posterior cingulate gyri in Alzheimer's disease spectrum using 3-tesla MR spectroscopy.
    Lim TS, Hong YH, Lee HY, Choi JY, Kim HS, Moon SY.
    Dement Geriatr Cogn Disord; 2012 Apr; 33(2-3):149-55. PubMed ID: 22722669
    [Abstract] [Full Text] [Related]

  • 17. [Dementias: diagnostic contribution of imaging and proton magnetic resonance spectroscopy].
    Arana E, Martínez-Granados B, Marti-Bonmati L, Martínez-Bisbal MC, Gil A, Blasco C, Celda B.
    Neurologia; 2007 Jun; 22(5):267-74. PubMed ID: 17508300
    [Abstract] [Full Text] [Related]

  • 18. [Cerebral metabolism in patients with cognitive disorders: a combined MRS and PET study].
    Khomenko YG, Kataeva GV, Bogdan AA, Chernysheva EM, Susin DS.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019 Jun; 119(1):51-58. PubMed ID: 30778031
    [Abstract] [Full Text] [Related]

  • 19. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
    Almuqbel M, Melzer TR, Myall DJ, MacAskill MR, Pitcher TL, Livingston L, Wood KL, Keenan RJ, Dalrymple-Alford JC, Anderson TJ.
    Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939
    [Abstract] [Full Text] [Related]

  • 20. Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy.
    Modrego PJ, Pina MA, Fayed N, Díaz M.
    CNS Drugs; 2006 Jan; 20(10):867-77. PubMed ID: 16999455
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.